Originally published by our sister publication Pain Medicine News
By Myles Starr
The CDC has guidelines recommending that clinicians avoid using opioids to manage chronic noncancer pain. Now data published in JAMA Network Open indicate that as physicians heed opioid guidelines, prescriptions for skeletal muscle relaxants (SMRs) for chronic pain have risen—despite risks posed by SMRs and a lack of evidence supporting their long-term use (JAMA Network Open 2024;7[9]:e2434835).
“This